Multivariate SAR and QSAR of cucurbitacin derivatives as cytotoxic compounds in a human lung adenocarcinoma cell line

This article describes structure-activity relationship (SAR/QSAR) studies on the cytotoxic activity in a human lung adenocarcinoma cell line (A549) of 43 cucurbitacin derivatives. Modeling was performed using the methods partial least squares with discriminant analysis (PLS-DA) and PLS. For both stu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Lang, K.L
Otros Autores: Silva, I.T, Machado, V.R, Zimmermann, L.A, Caro, M.S.B, Simões, C.M.O, Schenkel, E.P, Durán, F.J, Bernardes, L.S.C, De Melo, E.B
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2014
Materias:
OPS
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 24787caa a22021377a 4500
001 PAPER-23873
003 AR-BaUEN
005 20230518205538.0
008 190411s2014 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-84891502657 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a JMGMF 
100 1 |a Lang, K.L. 
245 1 0 |a Multivariate SAR and QSAR of cucurbitacin derivatives as cytotoxic compounds in a human lung adenocarcinoma cell line 
260 |c 2014 
270 1 0 |m De Melo, E.B.; Department of Pharmacy, Unioeste, 2069 Universitária St, 85819110 Cascavel, PR, Brazil; email: eduardo.b.de.melo@gmail.com 
506 |2 openaire  |e Política editorial 
504 |a Ganesan, A., The impact of natural products upon modern drug discovery (2008) Curr. Opin. Chem. Biol., 12, pp. 306-317 
504 |a Newman, D.J., Cragg, G.M., Natural products as sources of new drugs over the 30 years from 1981 to 2010 (2012) J. Nat. Prod., 75, pp. 311-335 
504 |a Lang, K.L., Silva, I.T., Zimmermann, L.A., Machado, V.R., Teixeira, M.R., Lapuh, M.I., Galetti, M.A., Durán, F.J., Synthesis and cytotoxic activity evaluation of dihydrocucurbitacin B and cucurbitacin B derivatives (2012) Bioorg. Med. Chem., 20, pp. 3016-3030 
504 |a Miró, M., Cucurbitacins and their pharmacological effects (1995) Phytother. Res., 9, pp. 159-168 
504 |a Jian, C.C., Ming, H.C., Rui, L.N., Cordel, G.A., Qiuz, S.X., Cucurbitacins and cucurbitane glycosides: Structures and biological activities (2005) Natural Product Reports, 22 (3), pp. 386-399. , DOI 10.1039/b418841c 
504 |a Ríos, J.L., Escandell, J.M., Recio, M.C., Atta Ur, R., New insights into the bioactivity of cucurbitacins (2005) Stud. Nat. Prod. Chem., 32, pp. 429-469 
504 |a Lee, D.H., Iwanski, G.B., Thoennissen, N.H., Cucurbitac: Ancient compound shedding new light on cancer treatment (2010) Sci. World J., 10, pp. 413-418 
504 |a Duncan, K.L.K., Duncan, M.D., Alley, M.C., Sausville, E.A., Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells (1996) Biochemical Pharmacology, 52 (10), pp. 1553-1560. , DOI 10.1016/S0006-2952(96)00557-6, PII S0006295296005576 
504 |a Escandell, J.M., Kaler, P., Recio, M.C., Sasazuki, T., Shirasawa, S., Augenlicht, L., Ríos, J.L., Klampfer, L., Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: The role of p53 and p21 (2008) Biochem. Pharmacol., 76, pp. 198-207 
504 |a Wakimoto, N., Yin, D., O'Kelly, J., Haritunians, T., Karlan, B., Said, J., Xing, H., Koeffler, H.P., Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo (2008) Cancer Sci., 99, pp. 1793-1797 
504 |a Shi, X., Franko, B., Frantz, C., Amin, H.M., Lai, R., JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells (2006) British Journal of Haematology, 135 (1), pp. 26-32. , DOI 10.1111/j.1365-2141.2006.06259.x 
504 |a Tannin-Spitz, T., Grossman, S., Dovrat, S., Gottlieb, H.E., Bergman, M., Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells (2007) Biochemical Pharmacology, 73 (1), pp. 56-67. , DOI 10.1016/j.bcp.2006.09.012, PII S0006295206005818 
504 |a Thoennissen, N.H., Iwanski, G.B., Doan, N.B., Okamoto, R., Lin, P., Abbassi, S., Song, J.H., Koeffler, H.P., Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells (2009) Cancer Res., 69, pp. 5876-5884 
504 |a Chan, K.T., Meng, F.Y., Li, Q., Ho, C.Y., Lam, T.S., To, Y., Lee, W.H., Toh, M., Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration (2010) Cancer Lett., 294, pp. 118-124 
504 |a Yang, L., Wu, S., Zhang, Q., Liu, F., Wu, P., 23,24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and mitochondria-dependent apoptosis in human breast cancer cells (Bcap37) (2007) Cancer Letters, 256 (2), pp. 267-278. , DOI 10.1016/j.canlet.2007.06.018, PII S0304383507002959 
504 |a Sun, J., Blaskovich, M.A., Jove, R., Livingston, S.K., Coppola, D., Sebti, S.M., Cucurbitacin Q: A selective STAT3 activation inhibitor with potent antitumor activity (2008) Oncogene, 27, p. 1344 
504 |a Blaskovich, M.A., Sun, J., Cantor, A., Turkson, J., Jove, R., Sebti, S.M., Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice (2003) Cancer Research, 63 (6), pp. 1270-1279 
504 |a Jayaprakasam, B., Seeram, N.P., Nair, M.G., Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana (2003) Cancer Letters, 189 (1), pp. 11-16. , DOI 10.1016/S0304-3835(02)00497-4, PII S0304383502004974 
504 |a Duncan, M.D., Duncan, K.L.K., Cucurbitacin E targets proliferating endothelia (1997) Journal of Surgical Research, 69 (1), pp. 55-60. , DOI 10.1006/jsre.1997.5028 
504 |a Nantasenamat, C., Isarankura-Na-Ayudhya, C., Naenna, T., Prachayasittikul, V., A practical overview of quantitative structure-activity relationship (2009) EXCLI J., 8, pp. 74-88 
504 |a Molfetta, F.A., Bruni, A.T., Rosselli, F.P., Da Silva, A.B.F., A partial least squares and principal component regression study of quinone compounds with trypanocidal activity (2007) Structural Chemistry, 18 (1), pp. 49-57. , DOI 10.1007/s11224-006-9120-3 
504 |a Qin, Y., Deng, H., Yan, H., Zhong, R., An accurate nonlinear QSAR model for the antitumor activities of chloroethylnitrosoureas using neural networks (2011) J. Mol. Graph. Model., 29, pp. 826-833 
504 |a Speck-Planche, A., Kleandrova, V.V., Luan, F., Cordeiro, M.N.D.S., Chemoinformatics in multi-target drug discovery for anti-cancer therapy: In silico design of potent and versatile anti-brain tumor agents (2012) Anticancer Agents Med. Chem., 12, pp. 678-685 
504 |a Speck-Planche, A., Kleandrova, V.V., Luan, F., Cordeiro, M.N.D.S., Chemoinformatics in anti-cancer chemotherapy: Multi-target QSAR model for the in silico discovery of anti-breast cancer agents (2012) Eur. J. Pharm. Sci., 47, pp. 273-279 
504 |a Lahl, U., Gundert-Remy, U., The use of (Q)SAR methods in the context of REACH (2008) Toxicology Mechanisms and Methods, 18 (2-3), pp. 149-158. , DOI 10.1080/15376510701857288, PII 791541689 
504 |a Dang, G.V., Rode, B.M., Stuppner, H., Quantitative electronic structure-activity relationship (QESAR) of natural cytotoxic compounds: Maytansinoids, quassinoids and cucurbitacins (1994) Eur. J. Pharm. Sci., 2, pp. 331-350 
504 |a Bartalis, J., Halaweish, F.T., In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines (2011) Bioorg. Med. Chem., 19, pp. 2757-2766 
504 |a Lang, K.L., Guimarães, T.R., Machado, V.R., Zimmermann, L.A., Silva, I.T., Teixeira, M.R., Durán, F.J., Schenkel, E.P., New cytotoxic cucurbitacins from Wilbrandia ebracteata Cogn. (2011) Planta Med., 77, pp. 1648-1651 
504 |a Machado, V.R., (2012) Semi-síntese de Derivados Glicosilados de Dihidrocucurbitacina B, Isolada de Wilbrandia Ebracteata Cogn, , Dissertation Pharmacy School, Universidade Federal de Santa Catarina 
504 |a Farias, M.R., Schenkel, E.P., Mayer, R., Rucker, G., Cucurbitacins as constituents of Wilbrandia ebracteata (1993) Planta Medica, 59 (3), pp. 272-275 
504 |a Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays (1983) Journal of Immunological Methods, 65 (1-2), pp. 55-63 
504 |a Barker, M., Rayens, W., Partial least squares for determination (2003) J. Chemom., 17, pp. 166-173 
504 |a Wold, S., Sjostrom, M., Eriksson, L., PLS-regression: A basic tool of chemometrics (2001) Chemometrics and Intelligent Laboratory Systems, 58 (2), pp. 109-130. , DOI 10.1016/S0169-7439(01)00155-1, PII S0169743901001551 
504 |a (2004) ChemOffice Ultra, Version 8.0, , Cambridge Soft Corporation Cambridge, USA 
504 |a (2009) Gaussian 09W, Version 7.0, , Gaussian Inc. Wallingford, USA 
504 |a O'Boyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T., Hutchison, G.R., Open Babel: An open chemical toolbox (2011) J. Cheminform., 3, p. 33 
504 |a (2009) Gauss View, Version 5.0, , Gaussian Inc. Wallingford, USA 
504 |a Todeschini, R., Consonni, V., (2009) Molecular Descriptors for Chemoinformatics, , 2nd ed. Wiley-VCH Weinheim 
504 |a (2011) Dragon User Guide, Version 6.0, , Talete srl. Italy 
504 |a Martins, J.P.A., Ferreira, M.M.C., QSAR modeling: A new open source computational package to generate and validate QSAR models (2013) Quim. Nova, 26, pp. 554-560 
504 |a González, M.P., Terán, C., Saíz-Urra, L., Teijeira, M., Variable selection methods in QSAR: An overview (2008) Curr. Top. Med. Chem., 8, pp. 1606-1627 
504 |a Teófilo, R.F., Martins, J.P., Ferreira, M.M.C., Sorting variables by using informative vectors as a strategy for feature selection in multivariate regression (2009) J. Chemom., 23, pp. 32-48 
504 |a Roy, P.P., Leonard, J.T., Roy, K., Exploring the impact of size of training sets for the development of predictive QSAR models (2008) Chemometrics and Intelligent Laboratory Systems, 90 (1), pp. 31-42. , DOI 10.1016/j.chemolab.2007.07.004, PII S0169743907001529 
504 |a Roy, P.P., Roy, K., On some aspects of variable selection for partial least squares regression models (2008) QSAR Comb. Sci., 27, pp. 302-313 
504 |a Camargo, L.T.F.M., Sena, M.M., Camargo, A.J., A quantum chemical and chemometrical study of indolo[2,1-b]quinazoline and their analogues with cytotoxic activity against breast cancer cells (2009) SAR QSAR Environ. Res., 20, pp. 537-549 
504 |a Dejaegher, B., Dhooghe, L., Goodarzi, M., Apers, S., Pieters, L., Heyden, Y.V., Classification models for neocryptolepine derivatives as inhibitors of the beta-haematin formation (2011) Anal. Chim. Acta, 705, pp. 98-110 
504 |a Askjaer, S., Langgad, M., Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation (2008) Journal of Chemical Information and Modeling, 48 (3), pp. 476-488. , DOI 10.1021/ci700356w 
504 |a Mitra, I., Saha, A., Roy, K., Chemometric QSAR modeling and in silico design of antioxidant NO donor phenols (2011) Sci. Pharm., 79, pp. 31-57 
504 |a Gaudio, A.C., Zandonade, E., Proposition, validation and analysis of QSAR models (2001) Quimica Nova, 24 (5), pp. 658-671 
504 |a Kiralj, R., Ferreira, M.M.C., Basic validation procedures for regression models in QSAR and QSPR studies: Theory and application (2009) J. Braz. Chem. Soc., 20, pp. 770-787 
504 |a Eriksson, L., Jaworska, J., Worth, A.P., Cronin, M.T.D., McDowell, R.M., Gramatica, P., Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs (2003) Environmental Health Perspectives, 111 (10), pp. 1361-1375 
504 |a Golbraikh, A., Shen, M., Xiao, Z., Xiao, Y.-D., Lee, K.-H., Tropsha, A., Rational selection of training and test sets for the development of validated QSAR models (2003) Journal of Computer-Aided Molecular Design, 17 (2-4), pp. 241-253. , DOI 10.1023/A:1025386326946 
504 |a Ojha, P.K., Mitra, I., Das, R.N., Roy, K., Further exploring rm2 metrics for validation of QSPR models (2011) Chemom. Intell. Lab. Syst., 107, pp. 194-205 
504 |a (2007) Pirouette, Version 4, , Informetrix Inc. USA 
504 |a Gramatica, P., Principles of QSAR models validation: Internal and external (2007) QSAR and Combinatorial Science, 26 (5), pp. 694-701. , DOI 10.1002/qsar.200610151 
504 |a Wold, S., Eriksson, L., Clementi, S., Statistical validation of QSAR results (1998) Chemometric Methods in Molecular Design, pp. 309-318. , H. van de Waterbeemd, Wiley-VCH Weinheim 
504 |a Consonni, V., Ballabio, D., Todeschini, R., Evaluation of model predictive ability by external validation techniques (2010) J. Chemom., 24, pp. 194-201 
504 |a Luan, F., Melo, A., Borges, F., Cordeiro, M.N.L.D.S., Affinity prediction on A3 adenosine receptor antagonists: The chemometric approach (2011) Bioorg. Med. Chem., 19, pp. 6853-6859 
504 |a Leao, M.B.C., Pavao, A.C., Espinoza, V.A.A., Taft, C.A., Bulnes, E.P., A multivariate model of chemical carcinogenesis (2005) Journal of Molecular Structure: THEOCHEM, 719 (1-3), pp. 129-135. , DOI 10.1016/j.theochem.2004.10.090 
504 |a Afantitis, A., Melagraki, G., Sarimveis, H., Koutentis, P.A., Markopoulos, J., Igglessi-Markopoulou, O., A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes (2006) Bioorganic and Medicinal Chemistry, 14 (19), pp. 6686-6694. , DOI 10.1016/j.bmc.2006.05.061, PII S0968089606004354 
504 |a Takano, A., Hashimoto, K.E.N., Ogawa, M., Koyanagi, J., Kurihara, T., Wakabayashi, H., Kikuchi, H., Tanaka, A., Tumor-specific cytotoxicity and type of cell death induced by naphtho[2,3-b]furan-4,9-diones and related compounds in human tumor cell lines: Relationship to electronic structure (2009) Anticancer Res., 29, pp. 455-464 
504 |a Hansch, C., Bonavida, B., Jazirehi, A.R., Cohen, J.J., Milliron, C., Kurup, A., Quantitative structure - Activity relationships of phenolic compounds causing apoptosis (2003) Bioorganic and Medicinal Chemistry, 11 (4), pp. 617-620. , DOI 10.1016/S0968-0896(02)00326-7, PII S0968089602003267 
504 |a Hansch, C., Jazirehi, A., Mekapati, S.B., Garg, R., Bonavida, B., QSAR of apoptosis induction in various cancer cells (2003) Bioorganic and Medicinal Chemistry, 11 (13), pp. 3015-3019. , DOI 10.1016/S0968-0896(03)00184-6 
504 |a De Souza, A.O., Pedrosa, M.T.C., Alderete, J.B., Cruz, A.F., Prado, M.A.F., Alves, R.B., Silva, C.L., Cytotoxicity, antitumoral and antimycobacterial activity of tetrazole and oxadiazole derivatives (2005) Pharmazie, 60 (5), pp. 396-397 
504 |a Arantes, F.F.P., Barbosa, L.C.A., Maltha, C.R.A., Demunera, A.J., Fidêncio, P.H., Carneiro, J.W.M., A quantum chemical and chemometric study of sesquiterpene lactones with cytotoxicity against tumor cells (2011) J. Chemom., 25, pp. 401-407 
504 |a Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C., Darnell Jr., J.E., Stat3 as an oncogene (1999) Cell, 98 (3), pp. 295-303. , DOI 10.1016/S0092-8674(00)81959-5 
504 |a Silva, I.R., Teixeira, M.R., Lang, K.L., Guimarães, T.R., Dudek, S.E., Durán, F.J., Ludwig, S., Simões, C.M.O., Proliferative inhibition and apoptotic mechanism on human non-small-cell lung cancer (A549 cells) of a novel cucurbitacin from Wilbrandia ebracteata Cogn. (2013) Int. J. Cancer Res., 9, pp. 54-68 
504 |a Abreu, R.M.V., Ferreira, C.F.R., Queiroz, M.J.R.P., QSAR model for predicting radical scavenging activity of di(hetero)arylamines derivatives of benzo[b]thiophenes (2009) Eur. J. Med. Chem., 44, pp. 1952-1958 
504 |a Gramatica, P., Papa, E., Marrocchi, A., Minuti, L., Taticchi, A., Quantitative structure-activity relationship modeling of polycyclic aromatic hydrocarbon mutagenicity by classification methods based on holistic theoretical molecular descriptors (2007) Ecotoxicology and Environmental Safety, 66 (3), pp. 353-361. , DOI 10.1016/j.ecoenv.2006.02.005, PII S0147651306000455 
504 |a Gupta, R.A., Gupta, A.K., Soni, L.K., Kaskhedikar, S.G., Study of physicochemical properties-antitubercular activity relationship of naphthalene-1,4-dione analogs: A QSAR approach (2009) Chem. Pap., 63, p. 723 
504 |a Nakhjiri, M., Safavi, M., Alipour, E., Emami, S., Atash, A.F., Jafari-Zavareh, M., Ardestani, S.K., Shafiee, A., Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study (2012) Eur. J. Med. Chem., 50, pp. 113-123 
504 |a Liu, X., Chen, J., Yu, H., Zhao, J., Giesy, J.P., Wang, X., Quantitative structure activity relationship (QSAR) for toxicity of chlorophenols on L929 cells in vitro (2006) Chemosphere, 64 (10), pp. 1619-1626. , DOI 10.1016/j.chemosphere.2006.04.091, PII S0045653506005364 
504 |a Zhou, W., Dai, Z., Chen, Y., Yuan, Z., Computational QSAR models with high-dimensional descriptor selection improve antitumor activity design of ARC-111 analogues (2013) Med. Chem. Res., 22, pp. 278-286 
504 |a Bhhatarai, B., Gramatica, P., Oral LD50 toxicity modeling and prediction of per- and polyfluorinated chemicals on rat and mouse (2011) Mol. Divers., 15, pp. 467-476 
504 |a Helguera, A.M., Cordeiro, M.N.D.S., Perez, M.A.C., Combes, R.D., Gonzalez, M.P., QSAR modeling of the rodent carcinogenicity of nitrocompounds (2008) Bioorganic and Medicinal Chemistry, 16 (6), pp. 3395-3407. , DOI 10.1016/j.bmc.2007.11.029, PII S0968089607009984 
504 |a Rasulev, B.F., Abdullaev, N.D., Syrov, V.N., Leszczynski, J., A Quantitative Structure-Activity Relationship (QSAR) study of the antioxidant activity of flavonoids (2005) QSAR and Combinatorial Science, 24 (9), pp. 1056-1065. , DOI 10.1002/qsar.200430013 
504 |a Ramírez-Galicia, G., Martínez-Pacheco, H., Garduño- Juárez, R., Deeb, O., Exploring QSAR of antiamoebic agents of isolated natural products by MLR, ANN, and RTO (2012) Med. Chem. Res., 21, pp. 2501-2516 
504 |a Hartmann, A.P., Jornada, D.H., Melo, E.B., A new fully validated and interpreted quantitative structure-activity relationship model of p-aminosalicylic acid derivatives as neuraminidase inhibitors (2013) Chem. Pap., 67, pp. 556-567 
504 |a Melo, E.B., Ferreira, M.M.C., A 4D structure-activity relationship model to predict HIV-1 integrase strand transfer inhibition using the LQTA-QSAR methodology (2012) J. Chem. Inf. Mod., 52, pp. 1722-1732 
504 |a Wold, S., PLS for multivariate linear modeling (1998) Chemometric Methods in Molecular Design, pp. 195-218. , H. van de Waterbeemd, Wiley-VCH Weinheim 
504 |a Kier, L.B., Hall, L.H., The electrotopological state: Structure modeling for QSAR and database analysis (1999) Topological Indices and Related Descriptors in QSAR and QSPR, pp. 491-562. , J. Devillers, A.T. Balaban, Gordon and Breach United Kingdom 
520 3 |a This article describes structure-activity relationship (SAR/QSAR) studies on the cytotoxic activity in a human lung adenocarcinoma cell line (A549) of 43 cucurbitacin derivatives. Modeling was performed using the methods partial least squares with discriminant analysis (PLS-DA) and PLS. For both studies, the variables were selected using the ordered predictor selection (OPS) algorithm. The SAR study demonstrated that the presence or absence of cytotoxic activity of the cucurbitacins could be described using information derived from their chemical structures. The QSAR study displayed suitable internal and external predictivity, and the selected descriptors indicated that the observed activity might be related to electrophilic attack on cellular structures or genetic material. This study provides improves the understanding of the cytotoxic activity of cucurbitacins and could be used to propose new cytotoxic agents. © 2013 Elsevier Inc.  |l eng 
536 |a Detalles de la financiación: Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq 
536 |a Detalles de la financiación: Agencia Nacional de Promoción Científica y Tecnológica 
536 |a Detalles de la financiación: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 
536 |a Detalles de la financiación: Fundação Araucária, 2010/7354 
536 |a Detalles de la financiación: 2671/2012-9 
536 |a Detalles de la financiación: Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina 
536 |a Detalles de la financiación: Universidad de Buenos Aires 
536 |a Detalles de la financiación: Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas 
536 |a Detalles de la financiación: Ministério da Ciência, Tecnologia e Inovação, MCTI, 472979/2011-6 
536 |a Detalles de la financiación: The Brazilian authors are grateful for financial support: Fundação Araucária (grant 2010/7354 ); Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, MCTI, grant 472979/2011-6 ); Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC/PRONEX, grant 2671/2012-9 ); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES/MEC) and CNPq/MCTI (for granting their research fellowships and resources PROAP). The Argentinian authors thank to Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) , Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT) and UBA (Univerdad de Buenos Aires) for financial support and research fellowships. Appendix A 
593 |a Department of Pharmacy, Federal University of Juiz de Fora (UFJF), Campus Governador Valadares, MG, Brazil 
593 |a Department of Pharmaceutical Sciences, Federal University of Santa Catarina (UFSC), Florianópolis, SC, Brazil 
593 |a Department of Chemistry, Federal University of Santa Catarina (UFSC), Florianópolis, SC, Brazil 
593 |a UMYMFOR-CONICET, Department of Organic Chemistry, University of Buenos Aires, Buenos Aires, Argentina 
593 |a Theoretical Medicinal and Environmental Chemistry Laboratory (LQMAT), Department of Pharmacy, Western Paraná State University (Unioeste), Cascavel, PR, Brazil 
690 1 0 |a CUCURBITACINS 
690 1 0 |a LUNG CANCER 
690 1 0 |a PLS 
690 1 0 |a PLS-DA 
690 1 0 |a QSAR 
690 1 0 |a CUCURBITACINS 
690 1 0 |a LUNG CANCER 
690 1 0 |a PLS 
690 1 0 |a PLS-DA 
690 1 0 |a QSAR 
690 1 0 |a CELL CULTURE 
690 1 0 |a DISCRIMINANT ANALYSIS 
690 1 0 |a LEAST SQUARES APPROXIMATIONS 
690 1 0 |a RESPIRATORY SYSTEM 
690 1 0 |a CYTOTOXICITY 
690 1 0 |a CUCURBITACIN DERIVATIVE 
690 1 0 |a CYTOTOXIC AGENT 
690 1 0 |a UNCLASSIFIED DRUG 
690 1 0 |a ANTINEOPLASTIC ACTIVITY 
690 1 0 |a ANTIPROLIFERATIVE ACTIVITY 
690 1 0 |a ARTICLE 
690 1 0 |a CARCINOMA CELL 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a DISCRIMINANT ANALYSIS 
690 1 0 |a HUMAN 
690 1 0 |a HUMAN CELL 
690 1 0 |a IC 50 
690 1 0 |a IN VITRO STUDY 
690 1 0 |a LUNG ADENOCARCINOMA 
690 1 0 |a PARTIAL LEAST SQUARES REGRESSION 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a QUANTITATIVE STRUCTURE ACTIVITY RELATION 
690 1 0 |a STRUCTURE ACTIVITY RELATION 
690 1 0 |a CUCURBITACINS 
690 1 0 |a LUNG CANCER 
690 1 0 |a PLS 
690 1 0 |a PLS-DA 
690 1 0 |a QSAR 
690 1 0 |a ANTINEOPLASTIC AGENTS 
690 1 0 |a CELL LINE, TUMOR 
690 1 0 |a CUCURBITACINS 
690 1 0 |a HUMANS 
690 1 0 |a INHIBITORY CONCENTRATION 50 
690 1 0 |a MODELS, CHEMICAL 
690 1 0 |a MULTIVARIATE ANALYSIS 
690 1 0 |a QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP 
650 1 7 |2 spines  |a OPS 
650 1 7 |2 spines  |a OPS 
650 1 7 |2 spines  |a OPS 
700 1 |a Silva, I.T. 
700 1 |a Machado, V.R. 
700 1 |a Zimmermann, L.A. 
700 1 |a Caro, M.S.B. 
700 1 |a Simões, C.M.O. 
700 1 |a Schenkel, E.P. 
700 1 |a Durán, F.J. 
700 1 |a Bernardes, L.S.C. 
700 1 |a De Melo, E.B. 
773 0 |d 2014  |g v. 48  |h pp. 70-79  |p J. Mol. Graph. Model.  |x 10933263  |t Journal of Molecular Graphics and Modelling 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891502657&doi=10.1016%2fj.jmgm.2013.12.004&partnerID=40&md5=fa40f39a88621031775ddc0f2dbd9bc3  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/j.jmgm.2013.12.004  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_10933263_v48_n_p70_Lang  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10933263_v48_n_p70_Lang  |y Registro en la Biblioteca Digital 
961 |a paper_10933263_v48_n_p70_Lang  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 84826